Clinical Report: Immune System Imbalance Contributes to Recurrence of Peritoneal Dialysis-Related Peritonitis
Overview
This study identifies biomarkers associated with relapsing peritoneal dialysis-associated peritonitis (PDAP) and highlights the role of immune dysregulation and gut bacterial translocation in relapse. The combination of conventional culture and 16S rDNA sequencing significantly improves pathogen detection rates.
Background
Relapsing PDAP presents a significant clinical challenge, often leading to prolonged antibiotic use and poor patient outcomes. Current diagnostic methods frequently fail to identify pathogens. This study aims to identify the role of immune responses in PDAP relapse.
Data Highlights
Method
Positivity Rate
Conventional Culture
64.5%
16S rDNA Sequencing
67.8%
Combined Methods
83.9%
Key Findings
Relapsing PDAP is linked to peritoneal immune dysregulation and gut bacterial translocation.
A biomarker panel (CCL28, CD40, uPA, NRTN) differentiates relapse from cure.
16S rDNA sequencing enhances pathogen detection rates to 83.9% when combined with conventional culture.
Proteomic profiling indicates downregulation of CCL28, CD40, and uPA, and upregulation of NRTN in the relapse group.
Bioinformatic analysis reveals dysregulation in pathways related to inflammation, fibrinolysis, and immune clearance.
Clinical Implications
The findings indicate the potential for integrating advanced diagnostic tools like 16S rDNA sequencing to facilitate timely interventions.
Conclusion
This study highlights the role of immune dysregulation in relapsing PDAP and the potential of advanced diagnostic methods.
